Primary aldosteronism comprises sporadic and genetic forms. Three forms of familial hyperaldosteronism have been described so far. In this chapter we discuss the genetic basis, clinical phenotypes, and diagnosis and therapy of familial hyperaldosteronism type I. This condition is caused by the presence of the chimeric CYP11B1/CYP11B2 gene and displays unique characteristics such as the normalization of blood pressure and aldosterone levels after dexamethasone administration, the hyperproduction of the hybrid steroids 18-hydroxycortisol and 18-oxocortisol, and an increased rate of cerebrovascular events.

Familial Hyperaldosteronism Type I

MULATERO, Paolo;MONTICONE, Silvia;VEGLIO, Franco;WILLIAMS, Tracy Ann
2014-01-01

Abstract

Primary aldosteronism comprises sporadic and genetic forms. Three forms of familial hyperaldosteronism have been described so far. In this chapter we discuss the genetic basis, clinical phenotypes, and diagnosis and therapy of familial hyperaldosteronism type I. This condition is caused by the presence of the chimeric CYP11B1/CYP11B2 gene and displays unique characteristics such as the normalization of blood pressure and aldosterone levels after dexamethasone administration, the hyperproduction of the hybrid steroids 18-hydroxycortisol and 18-oxocortisol, and an increased rate of cerebrovascular events.
2014
Primary Aldosteronism, Molecular Genetics, Endocrinology, and Translational Medicine
Springer
75
86
Glucocorticoid-remediable aldosteronism; Familial aldosteronism
Paolo Mulatero ; Silvia Monticone; Franco Veglio; Tracy Ann Williams
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/143903
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact